Research Topics
| C E FadulSummaryAffiliation: Dartmouth-Hitchcock Medical Center Country: USA Publications
| Collaborators
|
Detail Information
Publications
Agranulocytosis associated with lamotrigine in a patient with low-grade gliomaCamilo E Fadul
Section of Hematology Oncology, Department of Medicine, Dartmouth Hitchcock Medical Center, Dartmouth Medical School, Lebanon, New Hampshire 03756 0001, USA
Epilepsia 43:199-200. 2002..To report agranulocytosis associated with lamotrigine (LTG) in a patient with a brain tumor...- Immune modulation effects of concomitant temozolomide and radiation therapy on peripheral blood mononuclear cells in patients with glioblastoma multiformeCamilo E Fadul
Department of Medicine, Section of Hematology Oncology, Neuro Oncology Program, Norris Cotton Cancer Center, Dartmouth Hitchcock Medical Center, Lebanon, NH 03756, USA
Neuro Oncol 13:393-400. 2011..This shift can affect the outcome of immune therapy following RT-TMZ treatment and should be considered in the design of future combination therapy regimens... - A phase II study of thalidomide and irinotecan for treatment of glioblastoma multiformeCamilo E Fadul
Department of Medicine, Section of Hematology Oncology, Norris Cotton Cancer Center, Dartmouth Hitchcock Medical Center Drive, One Medical Center Drive, Lebanon, NH 03756, USA
J Neurooncol 90:229-35. 2008..To evaluate the combination of thalidomide and irinotecan, we conducted a phase II trial in adults with newly-diagnosed or recurrent GBM... - Immune response in patients with newly diagnosed glioblastoma multiforme treated with intranodal autologous tumor lysate-dendritic cell vaccination after radiation chemotherapyCamilo E Fadul
Section of Hematology Oncology Dartmouth Hitchcock Medical Center, One Medical Center Drive, Lebanon, NH 03756, USA
J Immunother 34:382-9. 2011..Our data suggest that DC vaccination in combination with radiation and chemotherapy in patients with GBM is feasible, safe, and may induce tumor-specific immune responses... - Long-term response of pituitary carcinoma to temozolomide. Report of two casesCamilo E Fadul
Department of Medicine, Section of Hematology Oncology, Dartmouth Hitchcock Medical Center, Lebanon, New Hampshire 03756 0001, USA
J Neurosurg 105:621-6. 2006..These two examples demonstrate that temozolomide may be effective in treating pituitary carcinomas and thus should be considered in the treatment algorithm for these difficult cases... - Focal paraneoplastic limbic encephalitis presenting as orgasmic epilepsyC E Fadul
Department of Medicine Sections of Hematology Oncology and Neurology, Dartmouth Hitchcock Medical Center, Norris Cotton Cancer Center, One Medical Center Drive, Lebanon, NH 03756 0001, USA
J Neurooncol 72:195-8. 2005..To report orgasmic epilepsy as a manifestation of paraneoplastic limbic encephalitis in a patient with small cell lung cancer... - Efficacy of thalidomide for the treatment of amyotrophic lateral sclerosis: a phase II open label clinical trialElijah W Stommel
Department of Medicine Section of Neurology, Dartmouth Hitchcock Medical Center, Lebanon, New Hampshire 03756, USA
Amyotroph Lateral Scler 10:393-404. 2009..In conclusion, treatment of ALS with the TNF-alpha inhibitor, thalidomide, does not appear to effectively modulate disease progression and can cause adverse effects... - A Phase II trial of paclitaxel and topotecan with filgrastim in patients with recurrent or refractory glioblastoma multiforme or anaplastic astrocytomaJ Marc Pipas
Neuro Oncology Program, Dartmouth Hitchcock Medical Center, Norris Cotton Cancer Center, 1 Medical Center Drive, New Hampshire, Lebanon, NH 03756, USA
J Neurooncol 71:301-5. 2005..We conducted a Phase II trial of these agents in combination with filgrastim (G-CSF) in patients with recurrent or refractory glioblastoma multiforme or anaplastic astrocytoma... - Atypical teratoid/rhabdoid tumor of the spine in an adult: case report and review of the literatureElena L Zarovnaya
Department of Pathology, Dartmouth Hitchcock Medical Center, One Medical Center Drive, Lebanon, NH 03756, USA
J Neurooncol 84:49-55. 2007..An unrestricted autopsy was performed. To our knowledge, this is the first case of a spinal atypical teratoid/rhabdoid tumor in an adult fully documented with molecular, immunohistochemical, cytogenetic and autopsy findings... - Cytotoxic chemotherapeutic management of newly diagnosed glioblastoma multiformeCamilo E Fadul
Neuro-Oncology Program, Norris Cotton Cancer Center, Dartmouth Hitchcock Medical Center, Dartmouth Medical School, Lebanon, NH, USA
J Neurooncol 89:339-57. 2008 - Brain metastases from colorectal cancer: risk factors, incidence, and the possible role of chemokinesJohn P Mongan
Department of Internal Medicine, Dartmouth Hitchcock Medical Center, Lebanon, NH 03756, USA
Clin Colorectal Cancer 8:100-5. 2009.... - Temozolomide therapy in a man with an aggressive prolactin-secreting pituitary neoplasm: Morphological findingsKalman Kovacs
Department of Laboratory Medicine, St Michael s Hospital, University of Toronto, Toronto, Ontario, Canada M5B 1W8
Hum Pathol 38:185-9. 2007..Based on the clinical, laboratory, and morphological findings, we recommend temozolomide therapy in patients with pituitary tumors not responding adequately to other treatment options... - Antitumour effects of temozolomide in a man with a large, invasive prolactin-producing pituitary neoplasmLuis V Syro
Clin Endocrinol (Oxf) 65:552-3. 2006 - Recurrent meningioma: salvage therapy with long-acting somatostatin analogueMarc C Chamberlain
Department of Interdisciplinary Oncology, H Lee Moffitt Cancer Center, Tampa, FL, USA
Neurology 69:969-73. 2007..The addition of somatostatin inhibits meningioma growth in vitro in some studies. There have been anecdotal reports of octreotide inhibiting growth in meningiomas...